{"transactions":[{"id":743657,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T23:44:43.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":8150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 8, 2026, in connection with the Reporting Person's election to the Issuer's board of directors at its 2026 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,150 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2026, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8150,"derivative":{"exercise_price":2.91,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":8150},"source":{"system":"sec-edgar","filing":"0001437749-26-020216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774926020216/rdgdoc.xml","form_type":"4"}},{"id":1101917,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:02:45.000Z","date":"2025-06-23","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 23, 2025, in connection with the Reporting Person's election to the Issuer's board of directors at its 2025 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 8,100 shares of the Issuer's common stock under the Issuer's 2025 Equity Incentive Plan in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2025, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":8100,"derivative":{"exercise_price":6.52,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":8100},"source":{"system":"sec-edgar","filing":"0001437749-25-021272","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925021272/rdgdoc.xml","form_type":"4"}},{"id":1479589,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:20:01.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 14, 2024, in connection with the Reporting Person's election to the Issuer's board of directors at its 2024 Annual Meeting of Stockholders, the Reporting Person was granted an option to purchase 5,750 shares of the Issuer's common stock under the Issuer's 2015 Equity Incentive Plan, as amended, in accordance with the terms of the Issuer's non-employee director compensation policy. The shares of common stock underlying the award will vest on a monthly basis over a one-year period in substantially equal 1/12th increments on the last day of each month beginning on June 30, 2024, subject to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":5750,"derivative":{"exercise_price":19.01,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":5750},"source":{"system":"sec-edgar","filing":"0001437749-24-020409","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924020409/rdgdoc.xml","form_type":"4"}},{"id":1780421,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T22:53:26.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":6450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":6450,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":6450},"source":{"system":"sec-edgar","filing":"0001437749-23-026074","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026074/rdgdoc.xml","form_type":"4"}},{"id":2330187,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":39784,"kind":"person","name":"Sabbagh Marwan","position":1,"cik":"0001917672","reported_name":"Sabbagh Marwan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-16T22:33:46.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":22058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal annual installments over the three-year period following the grant date of March 14, 2022."}],"balance_after":22058,"derivative":{"exercise_price":4.79,"expiration_date":"2032-03-13","underlying":"Common Stock","underlying_shares":22058},"source":{"system":"sec-edgar","filing":"0001209191-22-019311","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919122019311/doc4.xml","form_type":"4"}}]}